RecruitingNCT06806488
Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas
Retrospective Observational Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Enrollment
160 participants
Start Date
May 1, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
This is a purely retrospective and observational monocentric study
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Marginal zone lymphoma patients who were diagnosed and treated in our Hospital between December 2012 and December 2018.
- Age ≥ 18 years at enrolment.
- Written informed consent (if applicable)
Exclusion Criteria1
- none
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06806488